Background: Vitamin D is a potent inhibitor of the proinflammatory response and thereby diminishes turnover of leukocytes. Leukocyte telomere length (LTL) is a predictor of aging-related disease and decreases with each cell cycle and increased inflammation. Objective: The objective of the study was to examine whether vitamin D concentrations would attenuate the rate of telomere attrition in leukocytes, such that higher vitamin D concentrations would be associated with longer LTL. Design: Serum vitamin D concentrations were measured in 2160 women aged 18 -79 y (mean age: 49.4) from a large populationbased cohort of twins. LTL was measured by using the Southern blot method. Results: Age was negatively correlated with LTL (r ҃ Ҁ0.40, P 0.0001). Serum vitamin D concentrations were positively associated with LTL (r ҃ 0.07, P ҃ 0.0010), and this relation persisted after adjustment for age (r ҃ 0.09, P 0.0001) and other covariates (age, season of vitamin D measurement, menopausal status, use of hormone replacement therapy, and physical activity; P for trend across tertiles ҃ 0.003). The difference in LTL between the highest and lowest tertiles of vitamin D was 107 base pairs (P ҃ 0.0009), which is equivalent to 5.0 y of telomeric aging. This difference was further accentuated by increased concentrations of C-reactive protein, which is a measure of systemic inflammation. Conclusion: Our findings suggest that higher vitamin D concentrations, which are easily modifiable through nutritional supplementation, are associated with longer LTL, which underscores the potentially beneficial effects of this hormone on aging and age-related diseases.
INTRODUCTION
Mounting evidence suggests that, in addition to its welldescribed roles in skin, bone, and muscle physiology (2) , the hormone vitamin D acts as an inhibitor of the inflammatory response through several pathways (1) . Decreased vitamin D concentrations have been associated with an increased risk of developing autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes (3) (4) (5) (6) . Vitamin D administration has been shown to prevent the initiation and to attenuate the severity of immune-mediated diseases, including type 1 diabetes (7, 8) and an animal model for multiple sclerosis (9) . In addition, a recent open-label trial showed that vitamin D decreased rheumatoid arthritis disease activity (10) .
Subsets of leukocytes have receptors for the active form of vitamin D (1,25-dihydroxyvitamin D 3 ; 11-13) that support the direct effect of vitamin D on these cells (14 -16) , which explains, in part, the connections between vitamin D and autoimmune disease. Furthermore, an inverse relation has been shown between vitamin D concentrations and C-reactive protein (CRP), a marker of inflammation, in both healthy subjects and patients with rheumatoid arthritis and frailty (17, 18) . The inhibitory effect of vitamin D on the inflammatory response also points to a potential link between this vitamin and telomere dynamics (length and attrition rate) in leukocytes.
Telomeres are the ends of chromosomes and undergo attrition with each replication (19, 20) , a process that is accelerated by oxidative stress (21, 22) . What is more, leukocyte telomere length (LTL) is relatively short in persons with chronic inflammation, because the inflammatory response entails an increase in leukocyte turnover. Consistent with this proposition, both vascular diseases (23) (24) (25) (26) (27) (28) and autoimmune diseases such as lupus (29) and arthritis (30, 31) have been associated with shorter LTL. Furthermore, cigarette smoking and obesity, which provoke a proinflammatory milieu, are both a source of oxidative stress (32, 33) and are associated with shortened LTL (34, 35) . In fact, several studies have documented associations of indexes of oxidative stress and inflammation with LTL (24, 27, 36) . Recently, a randomized case-control analysis showed that shortened LTL was an independent risk factor for coronary heart disease, and the magnitude of risk attributed to shortened LTL was similar to that for conventional risk factors (37) . Thus, shortened LTL seems to be a marker of aging-related diseases and conditions associated with an increased burden of oxidative stress and inflammation. Yet, little is known about the environmental factors, other than obesity and smoking, that may affect LTL.
As humans age, both LTL and vitamin D concentrations decrease (17, 38) , whereas inflammatory mediators increase (39, 40) . In addition, CRP, a marker of systemic inflammation, displays an inverse relation with vitamin D concentrations (17, 18) and LTL (24) . Given that vitamin D displays antiinflammatory properties, we hypothesized that it may attenuate the rate of LTL attrition. To this end, we examined the associations between LTL and serum 25-hydroxyvitamin D concentrations and CRP in a population-based cohort of women across a wide age spectrum.
SUBJECTS AND METHODS

Study population
We studied women from the TwinsUK cohort (see www. twinsuk.ac.uk), an ongoing adult twin registry examining several age-related phenotypes, which include osteoporosis, obesity, diabetes, and visual, endocrine, and cardiovascular diseases. The twins involved in the present study were previously shown to represent the general population of the United Kingdom (41) . The present study was approved by the Guy's and St Thomas' Hospital Ethics Committee and conformed with the Helsinki Declaration. Participants provided written informed consent.
Phenotypic variables
Body mass index, physical activity, smoking, serum insulin, CRP, and leptin concentrations were considered to be potential confounders according to previous studies that showed a relation between these variables and LTL (34, 42) . Physical activity was recorded as inactive, light, moderate, or heavy exercise during leisure time. This previously validated measure of activity correlated well with an in-depth measure of physical activity in the Dunbar Health Survey (43) . Decreased physical activity was recently shown to be associated with shorter telomere length (44) . Those subjects that reported current daily cigarette smoking were classified as daily smokers. To assess the relation between vitamin D supplementation and LTL, subjects were asked if they used vitamin D supplements.
Fasting serum insulin and glucose concentrations were measured by using methods described previously (45) . Fasting serum insulin concentrations were assayed by using a chemiluminescent Immulite kit (Diagnostics Products Corp, Los Angeles, CA). Serum leptin concentrations were measured after the subjects had fasted overnight by using a radioimmunoassay (Linco Research, St Louis, MO). 25-Hydroxyvitamin D concentrations were measured by using a radioimmunoassay kit (DiaSorin Inc, Stillwater, MN). This assay has a detection limit of 4 nmol/L, and the analytic CV of the method is 9.1% at 22 nmol/L. Serum CRP concentrations were measured by using an enzyme-linked immunosorbent assay. The lower limit of detection of this assay is 0.15 mg/L, and the assay has a CV of 8.7% at 0.5 mg/L.
Telomere length measurement
LTL was derived from the mean of the terminal restriction fragment length by using the Southern blot method on DNA extracted from peripheral leukocytes, as described elsewhere (26) . Each DNA sample was resolved in duplicate (on different gels). If the difference between the duplicates was 5%, a third measurement was performed, and the mean of the 2 results 5% apart was taken. This occurred in 5% of the samples. The CV of the terminal restriction fragment length assay in the present study was 1.5%. The Center of Human Development and Aging at the University of Medicine and Dentistry of New Jersey conducted the terminal restriction fragment length assays and was blinded to the identity of the subjects.
Statistical analyses
The normality of the variables was assessed, and 25-hydroxyvitamin D, CRP, and leptin concentrations were subsequently natural log-transformed. The relation between 25-hydroxyvitamin D concentrations and age-adjusted LTL was assessed by using a scatter plot with a fitted regression line. A Pearson's correlation coefficient was calculated between 25-hydroxyvitamin D concentrations, LTL, age-adjusted LTL, and CRP concentrations. The relation between 25-hydroxyvitamin D concentrations and LTL was further assessed by using standard linear regression techniques, after control for multiple covariates. These covariates included age, body mass index, fasting insulin and serum leptin concentrations, smoking status, CRP, physical activity level, season of 25-hydroxyvitamin D measurement, menopausal status, and use of hormone replacement therapy. Model selection was carried out by using the Bayesian Information Criterion, by which the potential confounders were analyzed by assessing the top 10 models as generated by the Bayesian Information Criterion and by including the variables that predicted LTL. If a variable had no effect on the relation between LTL and vitamin D, then the variable was removed from the model; however, if a variable altered the relation between LTL and vitamin D, that variable was included in the final model. The resultant linear regression residual plots were checked for violations of linear relations. A quadratic term was computed for age and was included in the regression analysis to further test for nonlinearity. This quadratic term did not affect the relation between 25-hydroxyvitamin D and LTL, nor did it predict LTL, and it was thus discarded from further analysis. To further assess the relation between multiply adjusted LTL and 25-hydroxyvitamin D concentrations, the study population was divided into tertiles of 25-hydroxyvitamin D, and the average LTL for each tertile and nonparametric test for trend across tertiles was calculated. This analysis was also repeated after the study population was divided into quintiles of 25-hydroxyvitamin D concentrations. Because vitamin D influences inflammation and LTL is reduced by increased levels of systemic inflammation, we divided the study population into those subjects with a CRP concentration ͧ2.0 or 2.0 mg/L, which is regarded as the lower limit for clinically detectable inflammation (46) . Moreover, some authors (47) have suggested that a CRP concentration ͧ10.0 or 10.0 mg/L more appropriately defines inflammation, and we therefore repeated our analysis by using this alternate threshold. A statistical interaction term between CRP and 25-hydroxyvitamin D was computed but was not statistically significant in linear regression models and was therefore not included in subsequent analyses. The difference in multiply adjusted LTL between current users of vitamin D supplements and nonusers was then calculated by using a 2-tailed Student's t test. Because of the nonindependence of twins, we controlled for familial aggregation by treating twinpairs as clusters of information by using the robust regression VITAMIN D AND TELOMERE LENGTH cluster option in STATA software (version 9.2; Stata Corp, College Station, TX). All analyses were carried out with the use of STATA/SE software (version 9.2; Stata Corp).
RESULTS
General characteristics
We identified a total of 2160 women with data on both 25-hydroxyvitamin D concentrations and LTL ( Table 1 We also stratified the study population by level of systemic inflammation by using a CRP concentration of 2.0 mg/L to designate the minimal inflammation status that may have clinical relevance (46) . We observed that, within each tertile of serum 25-hydroxyvitamin D, LTLs were longer in those with lower serum CRP concentrations (adjusted for age and level of physical activity; P for trend ҃ 0.001) than in subjects with higher CRP concentrations (Figure 2) . When assessing the most extreme groups, the difference in LTL between those with the lowest 25-hydroxyvitamin D concentrations and highest CRP concentrations and those with the highest 25-hydroxyvitamin D concentrations and lowest CRP concentrations was 164.6 base pairs, which was equivalent to 7.6 y of telomeric aging (P ҃ 0.0003 for difference in mean LTL between groups). To assess the sensitivity of the chosen CRP cutoff, we changed the CRP threshold to 10.0 mg/L. This did not change the relation between 25-hydroxyvitamin D and multiply adjusted LTL once stratified by CRP (P for nonparametric trend ҃ 0.001). In addition, for each tertile of 25-hydroxyvitamin D concentrations, those with higher CRP had shorter LTL (results not shown). The statistical interaction term between CRP and 25-hydroxyvitamin D was not significant.
25-OH-VITAMIN D (nmol/L) (log-transformed) LEUKOCYTE TELOMERE LENGTH (kb)
25-OH-VITAMIN D (nmol/L) (log-transformed) AGE-ADJUSTED LEUKOCYTE TELOMERE LENGTH (kb)
Vitamin D supplement information was available on a subset of the study population (n ҃ 700). Vitamin D supplement users had longer LTLs, despite adjustment for age, season of vitamin D measurement, menopausal status, use of hormone replacement therapy, and physical activity, than did nonusers. Mean adjusted LTL in subjects who did not use vitamin D supplements was 6.95 kb, whereas that of current users of vitamin D supplements was 7.06 kb; however, this difference was not statistically significant (P for 2-tailed Student's t test ҃ 0.06).
DISCUSSION
In the large population of women in the present study, higher serum 25-hydroxyvitamin D concentrations were associated with longer LTL. Moreover, in every tertile of vitamin D, LTL was shorter in individuals with higher CRP concentrations. The difference in multiply adjusted LTL between the highest and lowest serum vitamin D tertiles was similar in magnitude to the difference in LTL associated with 5 y of chronologic age. Although these associations do not prove causality, they do suggest that vitamin D may play an important role in the modulation of LTL, which is related to aging and age-related diseases. Previous studies indicated that shortened LTL is an independent risk factor for coronary heart disease (37), and our results suggest that vitamin D, which is easily modifiable through supplementation, may possibly attenuate LTL degradation. Vitamin D supplement users were also found to have longer LTLs than did nonusers, which provides support for this hypothesis. The reduction in total sample size by 1460 subjects in this subset analysis of vitamin supplement use possibly explains why this difference was only of borderline significance. However, direct measurement of serum 25-hydroxyvitamin D concentrations is likely a better proxy for vitamin D status that is the use of supplements alone.
There are several mechanisms that may explain the association between LTL and vitamin D concentrations. Vitamin D decreases the mediators of systemic inflammation, such as interleukin-2 and tumor necrosis factor-␣ (48), and, confirming this, in our study population, vitamin D concentrations were negatively correlated with levels of CRP. Vitamin D receptors are ubiquitously expressed in T and B lymphocytes, natural killer cells, and monocytes (49, 50) , and through the down-regulation of cytokines and other proinflammatory factors, vitamin D exerts profound antiinflammatory and antiproliferative actions, which would affect the turnover rate of leukocytes (1) . It follows that vitamin D would attenuate the rate of LTL attrition.
Inflammation and oxidative stress are key determinants in the biology of aging (51), and LTL dynamics appear to chronicle the accruing burden of these variables (52) . The present study further supports the concept that LTL may serve as a cumulative index of an individual's lifelong burden of oxidative stress and inflammation (52) . Some of the factors that heighten oxidative stress and inflammation are genetic, but others are clearly environmental in nature, and a few may be easily modifiable. For instance, cigarette smoking (34, 35) , obesity (34) , and sedentary lifestyle (44) are associated with shortened LTL. Whereas these lifestyle habits may be difficult to change, vitamin D concentrations are easily modifiable through nutritional supplementation or sunshine exposure.
We note the limitation of the cross-sectional approach of studying LTL, which may represent cumulative lifetime exposure to oxidative stress and inflammatory burden. In contrast, serum vitamin D concentrations represent the status of the vitamin at a certain time point. Therefore, longitudinal studies with multiple time points would provide a much more coherent account of the effect of different variables, including vitamin D, on leukocyte telomere dynamics. For example, longitudinal studies indicate that insulin resistance explains 28% (53) of the variation in leukocyte telomere attrition, whereas cross-sectional studies of this relation show that insulin resistance explains only 2.5% of the variation in LTL (27) . The reason for this is that LTL is highly variable at birth (54) and is as variable afterward. Thus, crosssectional studies of LTL may not always capture reliably the effect of a given factor on LTL attrition rate. On the basis of these considerations, our findings suggest that the effect of vitamin D on leukocyte telomere attrition may not be at all trivial.
We also note that the observations afforded by twin pairs in our cohort are not necessarily independent, and we have thus controlled for nonindependence by using robust statistical methods. Furthermore, our twin cohort was shown to be similar to the general population of the United Kingdom (41) . Finally, our results are cross-sectional and therefore may only suggest causality.
In conclusion, our study provides evidence that a longer LTL is associated with increased serum vitamin D concentrations in women. Although both LTL and serum vitamin D concentrations decrease with age and are thus possible markers of aging in general, we have shown that the positive association between LTL and vitamin D concentrations is independent of age and many other covariates. Vitamin D exerts immunomodulatory effects that may attenuate LTL attrition rate. Longitudinal studies or randomized controlled trials of supplementation exploring the effect of vitamin D on LTL will be necessary to unequivocally establish the relation between vitamin D and leukocyte telomere dynamics; but for the moment, our data suggest another potential benefit of vitamin D-on the aging process and age-related disease.
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